Adlai Nortye (ANL) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ANL Stock Alerts $13.25 -0.65 (-4.68%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12, 2024 | americanbankingnews.comAdlai Nortye Ltd. (NASDAQ:ANL) Short Interest UpdateApril 30, 2024 | marketbeat.comAdlai Nortye (NASDAQ:ANL) Shares Gap Down to $14.80Adlai Nortye (NASDAQ:ANL) Shares Gap Down to $14.80April 25, 2024 | marketbeat.comCantor Fitzgerald Research Analysts Raise Earnings Estimates for Adlai Nortye Ltd. (NASDAQ:ANL)Adlai Nortye Ltd. (NASDAQ:ANL - Free Report) - Analysts at Cantor Fitzgerald raised their FY2024 EPS estimates for Adlai Nortye in a research note issued on Tuesday, April 23rd. Cantor Fitzgerald analyst L. Chen now expects that the company will post earnings per share of ($2.41) for the year, upApril 23, 2024 | marketbeat.comAdlai Nortye (NASDAQ:ANL) Stock Price Down 5.7%Adlai Nortye (NASDAQ:ANL) Stock Price Down 5.7%April 22, 2024 | marketbeat.comAdlai Nortye (NASDAQ:ANL) Shares Gap Up to $12.40Adlai Nortye (NASDAQ:ANL) Shares Gap Up to $12.40April 19, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 11:04 AM with a stated reason of "LULD pause."April 12, 2024 | marketbeat.comShort Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Expands By 42.9%Adlai Nortye Ltd. (NASDAQ:ANL - Get Free Report) was the target of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 6,000 shares, a growth of 42.9% from the March 15th total of 4,200 shares. Based on an average trading volume of 4,900 shares, the short-interest ratio is presently 1.2 days.April 8, 2024 | marketbeat.comAdlai Nortye (NASDAQ:ANL) Shares Gap Up to $8.29Adlai Nortye (NASDAQ:ANL) Shares Gap Up to $8.29April 8, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 11:04 AM with a stated reason of "LULD pause."April 8, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 11:04 AM with a stated reason of "LULD pause."April 8, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 10:04 AM with a stated reason of "LULD pause."April 8, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 10:04 AM with a stated reason of "LULD pause."April 8, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 09:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 8, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 10:04 AM with a stated reason of "LULD pause."April 8, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 09:04 AM with a stated reason of "LULD pause."April 5, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 03:04 PM with a stated reason of "LULD pause."March 29, 2024 | finance.yahoo.comAdlai Nortye Ltd.'s (NASDAQ:ANL) largest shareholders are retail investors with 59% ownership, insiders own 16%March 29, 2024 | marketbeat.comAdlai Nortye Ltd. (NASDAQ:ANL) Sees Large Growth in Short InterestAdlai Nortye Ltd. (NASDAQ:ANL - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 4,200 shares, an increase of 55.6% from the February 29th total of 2,700 shares. Based on an average daily volume of 1,200 shares, the days-to-cover ratio is presently 3.5 days.March 29, 2024 | globenewswire.comAdlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & DevelopmentMarch 15, 2024 | marketbeat.comShort Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Drops By 22.9%Adlai Nortye Ltd. (NASDAQ:ANL - Get Free Report) was the target of a large drop in short interest in February. As of February 29th, there was short interest totalling 2,700 shares, a drop of 22.9% from the February 14th total of 3,500 shares. Based on an average trading volume of 1,400 shares, the short-interest ratio is currently 1.9 days.March 11, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 12:03 PM with a stated reason of "LULD pause."February 9, 2024 | marketbeat.comTrading was temporarily halted for "ANL" at 09:02 AM with a stated reason of "LULD pause."February 5, 2024 | finance.yahoo.comAdlai Nortye Ltd. Announces Pricing of Initial Public OfferingFebruary 5, 2024 | finance.yahoo.comAdlai Nortye Ltd. Announces Closing of Initial Public OfferingFebruary 5, 2024 | finance.yahoo.comAdlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster AwardFebruary 5, 2024 | finance.yahoo.comAdlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC Get Adlai Nortye News Delivered to You Automatically Sign up to receive the latest news and ratings for ANL and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry ANL Media Mentions By Week ANL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANL News Sentiment▼-1.000.42▲Average Medical News Sentiment ANL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANL Articles This Week▼01▲ANL Articles Average Week Get Adlai Nortye News Delivered to You Automatically Sign up to receive the latest news and ratings for ANL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Travere Therapeutics News KalVista Pharmaceuticals News Astria Therapeutics News Y-mAbs Therapeutics News Entrada Therapeutics News Corbus Pharmaceuticals News Esperion Therapeutics News Verve Therapeutics News Applied Therapeutics News Olema Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adlai Nortye Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.